| scholarly article | Q13442814 |
| P2093 | author name string | Eugenio Gaudio | |
| Caterina Anania | |||
| Claudio Chiesa | |||
| Lucia Pacifico | |||
| Sara Romaggioli | |||
| Antonio De Merulis | |||
| John Frederick Osborn | |||
| P2860 | cites work | Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease | Q85522550 |
| Early left ventricular abnormality/dysfunction in obese children affected by NAFLD | Q86516556 | ||
| Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease | Q87388119 | ||
| Obesity, Inflammation, and Insulin Resistance | Q22250939 | ||
| Association between liver-specific gene polymorphisms and their expression levels with nonalcoholic fatty liver disease | Q28943559 | ||
| Monocyte and macrophage heterogeneity | Q29547438 | ||
| Alternative activation of macrophages: mechanism and functions | Q29614350 | ||
| Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states | Q29615208 | ||
| Macrophages in the pathogenesis of atherosclerosis | Q29617765 | ||
| Nonalcoholic fatty liver disease | Q29619354 | ||
| Alterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease. | Q30437623 | ||
| Evaluation of carotid artery stiffness in obese children using ultrasound radiofrequency data technology | Q30583357 | ||
| Imaging of subclinical atherosclerosis in children and young adults. | Q30702458 | ||
| Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes | Q33629852 | ||
| Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells | Q33994903 | ||
| Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents | Q34016080 | ||
| Lipid and macrophage accumulations in arteries of children and the development of atherosclerosis | Q34076657 | ||
| Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction | Q34216019 | ||
| Human epicardial adipose tissue is a source of inflammatory mediators | Q34272633 | ||
| Effects of PNPLA3 on Liver Fat and Metabolic Profile in Hispanic Children and Adolescents | Q34355263 | ||
| Lipid-induced insulin resistance: unravelling the mechanism | Q34370958 | ||
| Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease | Q34378263 | ||
| Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease | Q34395446 | ||
| PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease | Q34759018 | ||
| Adipokine resistin promotes in vitro angiogenesis of human endothelial cells | Q46974364 | ||
| Intima-media thickness in obese children before and after weight loss | Q47311546 | ||
| Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease | Q48030343 | ||
| Impaired left ventricular mechanics in nonalcoholic fatty liver disease: a speckle-tracking echocardiography study | Q48706253 | ||
| Left ventricular function by echocardiography, tissue Doppler imaging, and carotid intima-media thickness in obese adolescents with nonalcoholic fatty liver disease. | Q51222406 | ||
| Relationship between left ventricular mass and carotid intima media thickness in obese adolescents with non-alcoholic fatty liver disease. | Q51344436 | ||
| Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. | Q51970541 | ||
| Hepatic and cardiac steatosis: are they coupled? | Q53143925 | ||
| Arterial structure and function after recovery from the metabolic syndrome: the cardiovascular risk in Young Finns Study. | Q53180786 | ||
| Cardiovascular Risk Factors in Childhood and Carotid Artery Intima-Media Thickness in Adulthood | Q57417593 | ||
| Myocardial Triglyceride Content and Epicardial Fat Mass in Human Obesity: Relationship to Left Ventricular Function and Serum Free Fatty Acid Levels | Q57623044 | ||
| LPIN1 rs13412852 Polymorphism in Pediatric Nonalcoholic Fatty Liver Disease | Q57659836 | ||
| A common variant in the peroxisome proliferator–activated receptor-γ coactivator-1α gene is associated with nonalcoholic fatty liver disease in obese children | Q58329061 | ||
| A Common Variant in the PNPLA3 Gene is a Risk Factor for Non-Alcoholic Fatty Liver Disease in Obese Taiwanese Children | Q58329089 | ||
| Protective role of adiponectin on endothelial dysfunction induced by AGEs: A clinical and experimental approach | Q59744870 | ||
| Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease | Q62066904 | ||
| The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies | Q62607244 | ||
| Early intimal lesions in the common carotid artery | Q69205282 | ||
| Close relation of endothelial function in the human coronary and peripheral circulations | Q71827302 | ||
| Weight loss and progression of early atherosclerosis in the carotid artery: a four-year controlled study of obese subjects | Q73002386 | ||
| Lipotoxic diseases of nonadipose tissues in obesity | Q73318410 | ||
| Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment | Q79298129 | ||
| Nonalcoholic fatty liver disease (NAFLD) and cardiac lipotoxicity: Another piece of the puzzle | Q80415635 | ||
| NASH predicts plasma inflammatory biomarkers independently of visceral fat in men | Q80964439 | ||
| Secretory type II phospholipase A2 is produced and secreted by epicardial adipose tissue and overexpressed in patients with coronary artery disease | Q82233556 | ||
| Adipokine resistin is a key player to modulate monocytes, endothelial cells, and smooth muscle cells, leading to progression of atherosclerosis in rabbit carotid artery | Q83030634 | ||
| Adipocytokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosis | Q84009255 | ||
| Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease | Q85075933 | ||
| Inflammatory links between obesity and metabolic disease | Q35015802 | ||
| Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk | Q35171570 | ||
| Obesity, insulin resistance and free fatty acids | Q35204838 | ||
| Kupffer cells influence parenchymal invasion and phenotypic orientation, but not the proliferation, of liver progenitor cells in a murine model of liver injury | Q35235774 | ||
| Changes in the atherogenic risk factor profile according to degree of weight loss. | Q35279269 | ||
| A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents | Q35564927 | ||
| Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells | Q35569812 | ||
| Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes | Q35688259 | ||
| The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children. | Q35733564 | ||
| Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents | Q35783993 | ||
| Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex | Q36047487 | ||
| Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. | Q36269184 | ||
| The adipocyte as an active participant in energy balance and metabolism | Q36820181 | ||
| Insulin resistance: metabolic mechanisms and consequences in the heart. | Q36821424 | ||
| Diabetic cardiomyopathy revisited | Q36860318 | ||
| Ceramide is a cardiotoxin in lipotoxic cardiomyopathy | Q36870574 | ||
| Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group | Q36900139 | ||
| Fatty liver: a novel component of the metabolic syndrome | Q36906553 | ||
| Circulating levels of FGF-21 in obese youth: associations with liver fat content and markers of liver damage | Q36982020 | ||
| New role of resistin in lipopolysaccharide-induced liver damage in mice | Q37140377 | ||
| The role of adipokines in liver fibrosis | Q37207721 | ||
| Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link? | Q37217292 | ||
| Causes and metabolic consequences of Fatty liver | Q37250791 | ||
| Role of hepatic progenitor cells in nonalcoholic fatty liver disease development: cellular cross-talks and molecular networks | Q37291238 | ||
| Insulin resistance, inflammation, and non-alcoholic fatty liver disease | Q37301920 | ||
| Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart. | Q37335886 | ||
| Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity | Q37340863 | ||
| Advances in pediatric nonalcoholic fatty liver disease | Q37376332 | ||
| Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome | Q37487841 | ||
| Adipokines in liver diseases | Q37544637 | ||
| Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease | Q37794163 | ||
| Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease | Q37850396 | ||
| Monocyte and macrophage dynamics during atherogenesis | Q37890185 | ||
| Advances in pediatric nonalcoholic fatty liver disease | Q37957454 | ||
| Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials | Q37978785 | ||
| Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? | Q37992604 | ||
| Phenotypic and functional heterogeneity of macrophages and dendritic cell subsets in the healthy and atherosclerosis-prone aorta | Q37998021 | ||
| Nonalcoholic fatty liver disease and atherosclerosis | Q38052858 | ||
| Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis | Q38090905 | ||
| Ectopic fat, insulin resistance and non-alcoholic fatty liver disease | Q38106497 | ||
| Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men. | Q38318303 | ||
| Dietary intervention to reverse carotid atherosclerosis | Q38375356 | ||
| Ideal cardiovascular health in adolescence: effect of lifestyle intervention and association with vascular intima-media thickness and elasticity (the Special Turku Coronary Risk Factor Intervention Project for Children [STRIP] study). | Q38452548 | ||
| The relationship between pediatric nonalcoholic fatty liver disease and cardiovascular risk factors and increased risk of atherosclerosis in obese children | Q39572416 | ||
| A dietary and exercise intervention slows menopause-associated progression of subclinical atherosclerosis as measured by intima-media thickness of the carotid arteries | Q39593647 | ||
| Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force | Q39605814 | ||
| Vascular function in obese children with non-alcoholic fatty liver disease | Q39827340 | ||
| Fatty liver is a good indicator of subclinical atherosclerosis risk in obese children and adolescents regardless of liver enzyme elevation | Q42284823 | ||
| M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease | Q42710363 | ||
| Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease. | Q42732480 | ||
| Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease. | Q42870878 | ||
| I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease | Q42963113 | ||
| The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life. | Q43024330 | ||
| Severity of liver injury and atherogenic lipid profile in children with nonalcoholic fatty liver disease | Q43055877 | ||
| Cardiovascular risk factors, nonalcoholic fatty liver disease, and carotid artery intima-media thickness in an adolescent population in southern Italy | Q43067231 | ||
| Intima-media thickness and liver histology in obese children and adolescents with non-alcoholic fatty liver disease | Q43246350 | ||
| A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction | Q43603017 | ||
| Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive Type 2 diabetic individuals | Q43608961 | ||
| Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. | Q43886501 | ||
| Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents | Q44322582 | ||
| Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions | Q44735336 | ||
| Effects of diet and exercise on obesity-related vascular dysfunction in children | Q44832201 | ||
| Fatty liver is independently associated with alterations in circulating HDL2 and HDL3 subfractions | Q45234773 | ||
| Fluvastatin and lifestyle modification for reduction of carotid intima-media thickness and left ventricular mass progression in drug-treated hypertensives | Q45253413 | ||
| Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? | Q45266146 | ||
| Factors associated with insulin resistance and non-alcoholic fatty liver disease among youths. | Q46242854 | ||
| Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents | Q46458233 | ||
| Intima-media thickness of carotid artery and susceptibility to atherosclerosis in obese children with nonalcoholic fatty liver disease | Q46497057 | ||
| Fibroblast growth factor 21 protects against cardiac hypertrophy in mice. | Q46527697 | ||
| The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors. | Q46571703 | ||
| Nonalcoholic fatty liver disease and carotid atherosclerosis in children | Q46689926 | ||
| Relation of epicardial fat and alanine aminotransferase in subjects with increased visceral fat. | Q46788629 | ||
| Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver | Q46936115 | ||
| Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes | Q46944958 | ||
| P433 | issue | 27 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fatty liver disease | Q6058862 |
| teenager | Q1492760 | ||
| metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
| P304 | page(s) | 9055-9071 | |
| P577 | publication date | 2014-07-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Nonalcoholic fatty liver disease and the heart in children and adolescents | |
| P478 | volume | 20 |
| Q92856311 | A Systematic Review of NAFLD-Associated Extrahepatic Disorders in Youths |
| Q30248346 | Added Sugars and Cardiovascular Disease Risk in Children: A Scientific Statement From the American Heart Association. |
| Q26798155 | Association of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-Analysis |
| Q55497819 | EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease. |
| Q60462090 | EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease |
| Q26780254 | Endocrine causes of nonalcoholic fatty liver disease |
| Q88527580 | Feasibility of balanced steady-state free precession sequence at 1.5T for the evaluation of hepatic steatosis in obese children and adolescents |
| Q42330056 | From the liver to the heart: Cardiac dysfunction in obese children with non-alcoholic fatty liver disease |
| Q59798310 | Is There an Association of Vascular Disease and Atherosclerosis in Children and Adolescents With Obesity and Non-alcoholic Fatty Liver Disease? |
| Q57062900 | Magnetic Resonance Elastography of Liver: Current Update |
| Q33831717 | Pediatric Non-Alcoholic Fatty Liver Disease |
| Q89174252 | Prevalence of combined and noncombined dyslipidemia in an Iranian population |
| Q55167292 | Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease. |
| Q38689551 | The Association between Non-Alcoholic Fatty Liver Disease and Cardiovascular Risk in Children |
Search more.